Dr. Mikhail Kosiborod is a cardiologist, Vice President of Research at Saint Luke’s Health System, Director of Cardiometabolic Research and the Haverty Cardiometabolic Center of Excellence at Saint Luke’s Mid America Heart Institute, and Professor of Medicine at the University of Missouri-Kansas City. He serves as one of George Clinical’s scientific leaders. Dr. Maria Ali, CMO, […]
Read MoreBEIJING, December 19, 2019 – George Clinical, a global scientifically-backed clinical research organization (CRO), and Guangdong Provincial People’s Hospital (GDPH) have executed a memorandum of understanding (MoU) laying out broad collaboration in the area of clinical research in China. The memorandum outlines several areas the two organizations will pursue including: training and education in clinical […]
Read MoreGeorge Clinical and parent organization, The George Institute for Global Health, were recently recognized as Finalists in the 2019 Premier’s NSW Export Awards for the organizations’ important economic contribution through job creation and increased prosperity for the community. The prestigious national award was created to recognize outstanding export achievement by an enterprise in any industry […]
Read MoreWorld renown George Clinical Scientific Leaders, researchers and project operations teams attended and exhibited at ASN Kidney Week in Washington, DC November 5–10, 2019. Seven of our Scientific Leaders attended the ASN Kidney Week Conference: • Vivekanand Jha • David Wheeler • Meg Jardine • Martin Gallagher • Hiddo Lambers Heerspink • Muh Geot Wong • […]
Read MoreGeorge Clinical has once again gained recognition by the Mandatory Provident Fund (MPF) legislation for the provision of good MPF benefits to employees in Hong Kong. The Hong Kong office is part of a wide-ranging George Clinical East Asia team that includes offices in Hong Kong, Malaysia, South Korea, Taiwan, Philippines, Singapore and operational teams […]
Read MoreMembers of George Clinical management team were invited recently to an Investment Dialogue with the Prime Minister of the Netherlands at the Sydney Opera House. The intimate event included key business representatives, the Prime Minister, the Consul-General of the Kingdom of the Netherlands and Australia’s Consul-General to the Netherlands. A select group of companies were […]
Read MoreDr. Maria Ali, CMO, and Meg Jardine, MBBS, Associate Professor at the University of New South Wales and member of the CREDENCE steering committee, discuss the results and implications of the CREDENCE trial. Maria: As a physician, you’ve chosen to focus on research. Why is research like CREDENCE so important for healthcare in general and, […]
Read MoreThe George Institute has been named as one of 13 Australian organizations to receive an Athena SWAN Bronze Institution Award recognizing gender equity and diversity in the workforce. Part of the Science in Australia Gender Equity (SAGE) initiative, this is Australia’s gender equity program for higher education and research organizations in the medical sector. The […]
Read MoreThe George Institute for Global Health’s Co-Founder and Principal Director Dr. Robyn Norton has been nominated as one of The Australian Financial Review’s 2019 top 100 Women of Influence, recognizing her leadership and trailblazing efforts in global health and gender equity. The Women of Influence Award celebrate women leaders who have pushed back against unfairness, […]
Read MoreSYDNEY, October 8, 2019 – George Clinical, a global scientifically-driven clinical research organization (CRO), today announced the promotion of Sean Hart to the new role of Chief Business Officer. Hart, who joined George Clinical through the acquisition of Vector Oncology in 2017, will now lead business development functions globally for the organization. “Sean has demonstrated […]
Read More
